Srinivasa R Karra

This inventor holds 29 USPTO granted patents and 10 published patent applications, plus 9 CIPO patents and 13 EPO patents, primarily in Neurodegenerative Disease Treatment. Top assignees: Merck Patent Gmbh, Alkermes, Inc., Merck Serono S. a.. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Srinivasa R Karra. Retrieved from https://idiyas.com/inventor/srinivasa-r-karra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 10)

% Patents Active = 55.2

CIPO Patents = 9 (Patent Applications = 5)

EPO Patents = 13 (Patent Applications = 19)

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 97(Granted Patents)

Company Filing History:

Applied Research Systems Ars Holding N.v.

patents

Years Active: 2007-2026

Loading Chart...

Areas of Expertise:

Neurodegenerative Diseases

Kinase Inhibitors

Piperidino Compounds

Macrocyclic Compounds

Indole Derivatives

Heterocyclic Carboxamides

Amino Azaheterocyclic Carboxamides

Bicyclic Urea Compounds

Prostaglandin Agonists

Quinoline Derivatives

C-ring Modified Tricyclics

Arylamino N-heteroaryl Compounds

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12753188 - Substituted macrocyclic compounds and related methods of treatment (2026-10-06),

2. 12441710 - Substituted piperidino compounds and related methods of treatment (2025-10-14),

3. 12054495 - Substituted macrocyclic compounds and related methods of treatment (2024-08-06),

4. 12006330 - Substituted macrocyclic compounds and related methods of treatment (2024-06-11),

5. 11760747 - Substituted piperidino compounds and related methods of treatment (2023-09-19),

6. 11542276 - Substituted macrocyclic compounds and related methods of treatment (2023-01-03),

7. 11440899 - Pyrimidine TBK/IKKe inhibitor compounds and uses thereof (2022-09-13),

8. 10676433 - Indole derivatives and their use in neurodegenerative diseases (2020-06-09),

9. 10428080 - TBK/IKK inhibitor compounds and uses thereof (2019-10-01),

10. 10323000 - Indole derivatives and their use in neurodegenerative diseases (2019-06-18),

11. 10080753 - Heterocyclic carboxamides as modulators of kinase activity (2018-09-25),

12. 9988391 - TBK/IKK inhibitor compounds and uses thereof (2018-06-05),

13. 9938268 - C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof (2018-04-10),

14. 9931324 - Indolizine derivatives and their use in neurodegenerative diseases (2018-04-03),

15. 9546166 - Indolizine derivatives and their use in neurodegenerative diseases (2017-01-17),

Title: **Srinivasa R Karra: Innovator in Pharmaceutical Compounds**

Introduction

Srinivasa R Karra, based in Pembroke, MA, is a prominent inventor in the pharmaceutical field. With an impressive portfolio of 27 patents, his contributions have advanced the treatment of various medical conditions.

Latest Patents

Among his latest innovations are the patents related to "Substituted macrocyclic compounds and related methods of treatment." These compounds have shown potential in providing solutions for individuals suffering from narcolepsy or cataplexy. The patents detail both the compounds themselves and the associated pharmaceutical compositions and methods that can help in treating these conditions.

Career Highlights

Throughout his career, Karra has made significant strides in the pharmaceutical industry by working with reputable companies such as Merck Patent GmbH and Alkermes, Inc. His role in these organizations has been crucial in developing innovative treatments that benefit patients worldwide.

Collaborations

Srinivasa has had the opportunity to collaborate with notable colleagues, including Yufang Xiao and Andreas Goutopoulos. These partnerships have further enriched his work and have facilitated advancements in pharmaceutical research and development.

Conclusion

In conclusion, Srinivasa R Karra's contributions to the field of pharmaceuticals, through his patents and collaborations, exemplify innovation and a commitment to improving medical treatments. His work continues to impact the lives of many individuals in need of effective therapies.

Profile summary based on public USPTO records.